A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors

被引：0
|
作者：
Matthew G. Fury
Eric Sherman
Sofia Haque
Susan Korte
Donna Lisa
Ronglai Shen
Nian Wu
David Pfister
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Medicine, Head and Neck Medical Oncology Service
[2] Memorial Sloan-Kettering Cancer Center,Department of Radiology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Memorial Sloan-Kettering Cancer Center,Deparment of Pharmacology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Everolimus; Cisplatin; Phase I; Solid tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：591 / 598
页数：7
相关论文
共 50 条
  • [1] A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
    Fury, Matthew G.
    Sherman, Eric
    Haque, Sowa
    Korte, Susan
    Lisa, Donna
    Shen, Ronglai
    Wu, Nian
    Pfister, David
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 591 - 598
  • [2] Phase I study of everolimus (E) plus low-dose weekly cisplatin (C) for patients with advanced solid tumors
    Fury, M. G.
    Sherman, E. J.
    Wu, N.
    Haque, S.
    Lisa, D. M.
    Carlson, D.
    Pfister, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase I study of everolimus (E; RAD001) + low-dose weekly cisplatin (C) for patients with advanced solid tumors: Preliminary results
    Fury, M. G.
    Sherman, E.
    Stambuk, H.
    Haque, S.
    Lisa, D.
    Shen, R.
    Carlson, D.
    Pfister, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors
    Fakih, MG
    Creaven, PJ
    Ramnath, N
    Trump, D
    Javle, M
    Strychor, S
    Repinski, TV
    Zamboni, BA
    Schwarz, JK
    French, RA
    Zamboni, WC
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 5942 - 5949
  • [5] Phase I study of weekly irinotecan combined with weekly cisplatin in patients with advanced solid tumors
    Nakanishi, Y
    Takayama, K
    Wataya, H
    Izumi, M
    Minami, T
    Takano, K
    Inoue, K
    Osaki, S
    Kimotsuki, K
    Harada, T
    Hara, N
    CHEMOTHERAPY, 2002, 48 (04) : 205 - 210
  • [6] Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors
    Saltz, LB
    Spriggs, D
    Schaaf, LJ
    Schwartz, GK
    Ilson, D
    Kemeny, N
    Kanowitz, J
    Steger, C
    Eng, M
    Albanese, P
    Semple, D
    Hanover, CK
    Elfring, GL
    Miller, LL
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3858 - 3865
  • [7] Cisplatin-paclitaxel weekly schedule in advanced solid tumors: A phase I study
    Frasci, G
    Comella, P
    Parziale, A
    Casaretti, R
    Daponte, A
    Gravina, A
    DeRosa, L
    Gallipoli, A
    Comella, G
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 291 - 293
  • [8] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Brian A. Costello
    Mitesh J. Borad
    Yingwei Qi
    George P. Kim
    Donald W. Northfelt
    Charles Erlichman
    Steven R. Alberts
    Investigational New Drugs, 2014, 32 : 710 - 716
  • [9] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Costello, Brian A.
    Borad, Mitesh J.
    Qi, Yingwei
    Kim, George P.
    Northfelt, Donald W.
    Erlichman, Charles
    Alberts, Steven R.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 710 - 716
  • [10] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345